Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium
- 1 February 1992
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 166 (2) , 171-177
- https://doi.org/10.1002/path.1711660214
Abstract
Proliferative disorders of the endometrium may be associated with autocrine and paracrine actions between stromal and epithelial cells. To determine whether the stromal–epithelial relation with respect to oestrogen receptor (OR) and progesterone receptor (PR) is disturbed in (pre)malignant endometrium immunocytochemical OR and PR expression was quantitated by computerized image analysis. This was studied in the stromal and epithelial cells of endometrial specimens diagnosed as hyperplasia (n = 14), atypical hyperplasia (n = 16), and adenocarcinoma (n = 33). Paraffin sections were used for optimal preservation of histomorphology. A progressive loss of OR and PR content occurred with increasing malignant transformation. Stromal cells in atypical hyperplasia (P = 0.0007) and well‐differentiated adenocarcinoma (P = 0.0008) exhibited a relative loss of PR content as compared with epithelial cells (P = 0.036 and P = 0.17, respectively). In atypical hyperplasia, the decrease in stromal PR content was not in parallel with persistent stromal OR immunostaining. Furthermore, stromal PR expression in atypical hyperplasia was significantly (P = 0.004) lower than in the surrounding hyperplasia, whereas the stromal OR staining as well as the epithelial OR and PR staining did not differ significantly. These observations may reflect a disturbance in hormonal interrelationships between endometrial cells in the development of endometrial neoplasia, indicating that stroma may modulate epithelial growth by paracrine mechanisms.Keywords
This publication has 23 references indexed in Scilit:
- Revised FIGO staging for gynaecological cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasiaAmerican Journal of Obstetrics and Gynecology, 1989
- Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancerGynecologic Oncology, 1988
- Ultrastructural evidence of stromal/epithelial interactions in the human endometrial cycleAmerican Journal of Obstetrics and Gynecology, 1988
- Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometriumAmerican Journal of Obstetrics and Gynecology, 1988
- The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer riskBritish Journal of Cancer, 1988
- Endometrial Hyperplasia and MetaplasiaPublished by Springer Nature ,1987
- Restoration of normal morphology and estrogen responsiveness in cultured vaginal and uterine epithelia transplanted with stroma.Proceedings of the National Academy of Sciences, 1986
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985
- Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1985